Search Results - "SETALURI, Vijayasaradhi"

Refine Results
  1. 1

    Role of dual specificity phosphatases (DUSPs) in melanoma cellular plasticity and drug resistance by Singh, Mithalesh K., Altameemi, Sarah, Lares, Marcos, Newton, Michael A., Setaluri, Vijayasaradhi

    Published in Scientific reports (23-08-2022)
    “…Melanoma cells exhibit phenotypic plasticity that allows transition from a proliferative and differentiated phenotype to a more invasive and undifferentiated…”
    Get full text
    Journal Article
  2. 2

    Advances in Microengineered Platforms for Skin Research by Teertam, Sireesh Kumar, Setaluri, Vijayasaradhi, Ayuso, Jose M.

    Published in JID innovations (01-01-2025)
    “…The skin plays a critical role in human physiology, acting both as a barrier to environmental insults and as a window to environmental stimuli. Disruption of…”
    Get full text
    Journal Article
  3. 3

    microRNA-340 as a modulator of RAS–RAF–MAPK signaling in melanoma by Poenitzsch Strong, Ashley M., Setaluri, Vijayasaradhi, Spiegelman, Vladimir S.

    Published in Archives of biochemistry and biophysics (01-12-2014)
    “…•miR-340 is a novel inhibitor of tumorigenic phenotype in melanoma cells.•miR-340 inhibits RAS–RAF–MAPK signaling pathway.•miR-340 targets multiple components…”
    Get full text
    Journal Article
  4. 4

    Microtubule-Associated Proteins as Targets in Cancer Chemotherapy by BHAT, Kumar M. R, SETALURI, Vijayasaradhi

    Published in Clinical cancer research (15-05-2007)
    “…Natural and synthetic compounds that disrupt microtubule dynamics are among the most successful and widely used cancer chemotherapeutic agents. However, lack…”
    Get full text
    Journal Article
  5. 5

    Microfluidic Tumor-on-a-Chip Model to Study Tumor Metabolic Vulnerability by Ayuso, Jose M, Rehman, Shujah, Farooqui, Mehtab, Virumbrales-Muñoz, María, Setaluri, Vijayasaradhi, Skala, Melissa C, Beebe, David J

    “…Tumor-specific metabolic adaptations offer an interesting therapeutic opportunity to selectively destroy cancer cells. However, solid tumors also present…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    EPAC-RAP1 Axis-Mediated Switch in the Response of Primary and Metastatic Melanoma to Cyclic AMP by Rodríguez, Carlos I, Castro-Pérez, Edgardo, Prabhakar, Kirthana, Block, Laura, Longley, B Jack, Wisinski, Jaclyn A, Kimple, Michelle E, Setaluri, Vijayasaradhi

    Published in Molecular cancer research (01-12-2017)
    “…Cyclic AMP (cAMP) is an important second messenger that regulates a wide range of physiologic processes. In mammalian cutaneous melanocytes, cAMP-mediated…”
    Get full text
    Journal Article
  9. 9

    MicroRNA-340-mediated Degradation of Microphthalmia-associated Transcription Factor mRNA Is Inhibited by the Coding Region Determinant-binding Protein by Goswami, Srikanta, Tarapore, Rohinton S., TeSlaa, Jessica J., Grinblat, Yevgenya, Setaluri, Vijayasaradhi, Spiegelman, Vladimir S.

    Published in The Journal of biological chemistry (02-07-2010)
    “…Alternative cleavage and polyadenylation generate multiple transcript variants of mRNA isoforms with different length of 3′-untranslated region (UTR)…”
    Get full text
    Journal Article
  10. 10

    Induction of Autophagy and Inhibition of Melanoma Growth In Vitro and In Vivo by Hyperactivation of Oncogenic BRAF by Maddodi, Nityanand, Huang, Wei, Havighurst, Thomas, Kim, KyungMann, Jack Longley, B., Setaluri, Vijayasaradhi

    Published in Journal of investigative dermatology (01-06-2010)
    “…Activating mutations in NRAS and BRAF are found frequently in cutaneous melanomas. Because concurrent mutations of both BRAF and RAS are extremely rare, it is…”
    Get full text
    Journal Article
  11. 11

    Lupeol Inhibits Growth of Highly Aggressive Human Metastatic Melanoma Cells In vitro and In vivo by Inducing Apoptosis by SALEEM, Mohammad, MADDODI, Nityanand, MOHAMMAD ABU ZAID, KHAN, Naghma, BIN HAFEEZ, Bilal, ASIM, Mohammad, SUH, Yewseok, YUN, Jung-Mi, SETALURI, Vijayasaradhi, MUKHTAR, Hasan

    Published in Clinical cancer research (01-04-2008)
    “…Purpose: Poor prognosis of metastatic melanoma mandates the development of novel strategies for its treatment and prevention. In this study, the effect of…”
    Get full text
    Journal Article
  12. 12

    Bromodomain and extra-terminal domain (BET) proteins regulate melanocyte differentiation by Trivedi, Archit, Mehrotra, Aanchal, Baum, Caitlin E, Lewis, Brandon, Basuroy, Tupa, Blomquist, Thomas, Trumbly, Robert, Filipp, Fabian V, Setaluri, Vijayasaradhi, de la Serna, Ivana L

    Published in Epigenetics & chromatin (10-03-2020)
    “…Pharmacologic inhibition of bromodomain and extra-terminal (BET) proteins is currently being explored as a new therapeutic approach in cancer. Some studies…”
    Get full text
    Journal Article
  13. 13

    Numb Regulates Stability and Localization of the Mitotic Kinase PLK1 and Is Required for Transit through Mitosis by SCHMIT, Travis L, NIHAL, Minakshi, NDIAYE, Mary, SETALURI, Vijayasaradhi, SPIEGELMAN, Vladimir S, AHMAD, Nihal

    Published in Cancer research (Chicago, Ill.) (01-08-2012)
    “…Numb functions in progenitor cell fate determination and early development, but it is also expressed in postdevelopmental tissues and cancers where its role is…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Metabotropic glutamate receptor 6 signaling enhances TRPM1 calcium channel function and increases melanin content in human melanocytes by Devi, Sulochana, Markandeya, Yogananda, Maddodi, Nityanand, Dhingra, Anuradha, Vardi, Noga, Balijepalli, Ravi C., Setaluri, Vijayasaradhi

    Published in Pigment cell and melanoma research (01-05-2013)
    “…Summary Mutations in TRPM1, a calcium channel expressed in retinal bipolar cells and epidermal melanocytes, cause complete congenital stationary night…”
    Get full text
    Journal Article
  16. 16

    Calcium homeostasis in human melanocytes: role of transient receptor potential melastatin 1 (TRPM1) and its regulation by ultraviolet light by Devi, Sulochana, Kedlaya, Rajendra, Maddodi, Nityanand, Bhat, Kumar M R, Weber, Craig S, Valdivia, Hector, Setaluri, Vijayasaradhi

    “…Transient receptor potential melastatin (TRPM) is a subfamily of ion channels that are involved in sensing taste, ambient temperature, low pH, osmolarity, and…”
    Get more information
    Journal Article
  17. 17

    Melanoma Progression Inhibits Pluripotency and Differentiation of Melanoma-Derived iPSCs Produces Cells with Neural-like Mixed Dysplastic Phenotype by Castro-Pérez, Edgardo, Rodríguez, Carlos I., Mikheil, Dareen, Siddique, Shakir, McCarthy, Alexandra, Newton, Michael A., Setaluri, Vijayasaradhi

    Published in Stem cell reports (09-07-2019)
    “…Melanomas are known to exhibit phenotypic plasticity. However, the role cellular plasticity plays in melanoma tumor progression and drug resistance is not…”
    Get full text
    Journal Article
  18. 18

    Mutation in archain 1, a subunit of COPI coatomer complex, causes diluted coat color and Purkinje cell degeneration by Xu, Xinjie, Kedlaya, Rajendra, Higuchi, Hitoshi, Ikeda, Sakae, Justice, Monica J, Setaluri, Vijayasaradhi, Ikeda, Akihiro

    Published in PLoS genetics (20-05-2010)
    “…Intracellular trafficking is critical for delivering molecules and organelles to their proper destinations to carry out normal cellular functions. Disruption…”
    Get full text
    Journal Article
  19. 19

    Delphinidin inhibits cell proliferation and invasion via modulation of Met receptor phosphorylation by Syed, Deeba N., Afaq, Farrukh, Sarfaraz, Sami, Khan, Naghma, Kedlaya, Rajendra, Setaluri, Vijayasaradhi, Mukhtar, Hasan

    Published in Toxicology and applied pharmacology (15-08-2008)
    “…The HGF/Met signaling pathway is deregulated in majority of cancers and is associated with poor prognosis in breast cancer. Delphinidin, present in pigmented…”
    Get full text
    Journal Article
  20. 20